AFP and hepatocellular carcinoma: Glycans of MUC1 (CA15-3), carbohydrate antigen (CA19-9) and alpha-fetoprotein (AFP) are monitored for management of breast cancer, pancreatic cancer, and hepatocellular carcinoma (HCC), respectively [167].